A multisite surveillance study published in Pediatrics assessed trends and determinants of influenza antiviral use in hospitalized children across the United States before and during the late COVID-19...
From respiratory syncytial virus monoclonal antibody approvals to thimerosal-free vaccine preferences, ACIP’s latest guidance has important implications for your practice.
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
Many pediatric patients who are recommended to receive two doses of the influenza vaccine do not receive both doses, despite vaccinations being associated with a significant decrease in the risk of...
An updated report for the use of the influenza vaccine and antiviral medications has been released from the American Academy of Pediatrics for the 2022-2023 influenza season.
In a recent study, researchers examined how repeated vaccination for influenza in children may increase antibodies that protect against other strains of influenza and how that association changes with age....
The researchers assessed data on 30,000 children who had been admitted to the hospital for influenza who had been discharged from 49 children’s hospitals during the 2015-2020 influenza seasons.
